Detalhe da pesquisa
1.
Empagliflozin after Acute Myocardial Infarction.
N Engl J Med
; 390(16): 1455-1466, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587237
2.
Empagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med
; 388(2): 117-127, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331190
3.
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights from the EMPACT-MI Trial.
Circulation
; 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581389
4.
Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure.
Circulation
; 148(13): 1011-1022, 2023 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37621153
5.
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
N Engl J Med
; 385(16): 1451-1461, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34449189
6.
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR-Pooled analysis.
Diabetes Obes Metab
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38558314
7.
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
Eur Heart J
; 44(5): 396-407, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36478225
8.
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.
Eur Heart J
; 44(1): 41-50, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36254693
9.
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes.
Circulation
; 146(9): 676-686, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35762322
10.
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial.
Circulation
; 146(4): 279-288, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35377706
11.
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.
Circulation
; 145(3): 184-193, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34779658
12.
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction.
Circulation
; 146(14): 1046-1055, 2022 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36098051
13.
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
N Engl J Med
; 383(15): 1413-1424, 2020 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32865377
14.
Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial.
J Card Fail
; 29(10): 1345-1354, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558088
15.
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.
Eur Heart J
; 43(5): 416-426, 2022 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34878502
16.
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.
Eur Heart J
; 43(36): 3435-3446, 2022 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788657
17.
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced.
Circulation
; 143(4): 310-321, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33095032
18.
Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
Circulation
; 144(22): 1738-1746, 2021 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34649459
19.
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.
Circulation
; 143(4): 326-336, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33081531
20.
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial.
Circulation
; 143(4): 337-349, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33175585